Proficiency testing of immunohistochemical biomarker assays in breast cancer.
about
Banff Initiative for Quality Assurance in Transplantation (BIFQUIT): reproducibility of polyomavirus immunohistochemistry in kidney allografts.Immunohistochemical Performance of Estrogen and Progesterone Receptor Antibodies on the Dako Omnis Staining Platform: Evaluation in Multicenter Studies.Confirmation of a low HER2 positivity rate of breast carcinomas - limitations of immunohistochemistry and in situ hybridizationPlasma membrane proteomics and its application in clinical cancer biomarker discovery.Receptor-defined subtypes of breast cancer in indigenous populations in Africa: a systematic review and meta-analysis.HER2/neu testing in primary colorectal carcinoma.Microarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreementQuality assessment of HER2 testing by monitoring of positivity ratesImmunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests.Molecular profiling of individual tumor cells by hyperspectral microscopic imagingTechnical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens.Proficiency testing in immunohistochemistry--experiences from Nordic Immunohistochemical Quality Control (NordiQC)Use of standard markers and incorporation of molecular markers into breast cancer therapy: Consensus recommendations from an International Expert Panel.External quality assessment for immunohistochemistry: experiences from NordiQC.Clinical outcome of brain metastases differs significantly among breast cancer subtypesBanff initiative for quality assurance in transplantation (BIFQUIT): reproducibility of C4d immunohistochemistry in kidney allografts.PPARγ antagonist GW9662 induces functional estrogen receptor in mouse mammary organ culture: potential translational significance.Quality assurance trials for Ki67 assessment in pathology.Highly reproducible results of breast cancer biomarkers when analysed in accordance with national guidelines - a Swedish survey with central re-assessment.Tissue microarrays: leaping the gap between research and clinical adoption.[Determination of tumor biological parameters in breast cancer: round robin testing for quality assurance].[Translational research and diagnostics for breast cancer].[Receptor detection in breast cancer. A decade of quality assurance trials in German-speaking pathology].
P2860
Q30371017-B4FC66F7-F032-4DBD-9BCC-466C89EB4AE8Q33736780-DE12D40B-864F-4C03-93F5-9D7A4D936F10Q34071408-83C13F8F-E3D0-4A01-86EE-DB67CEF4002EQ34122107-E29E37E5-A457-4FEE-AB4F-A5C8CFBC3BD4Q34155727-3E1DFDEC-6408-416F-9A7D-E8B13A29E160Q34499615-41B59CE3-B97F-4B92-AC4E-97221EAD164AQ34820314-5D52CF0A-AC69-410F-AAC5-14DACDC9E7DDQ35183522-0A9F37E8-1B30-4188-8B77-15F6FF8D1EFEQ35759456-5E58448D-A414-4320-BC45-0818072EAC99Q35913941-28ECBB4E-7419-4A5E-A721-D8F3BC7B6D7EQ36070547-3CC60340-549C-415B-BEB6-7404A47F0771Q36573459-417F1FF3-1A0D-474C-A845-B7985BA5A9B9Q37862646-1826585A-7C21-409B-A5F5-4316A32DA394Q38435266-B0BA1126-F1F5-4F8C-BCA9-47CF4DD90EB1Q40977689-04E5E34D-D93D-44B2-8B9B-773F7A7A2E2BQ44180277-5F505363-F4FB-44A2-833E-F7CB9BB66941Q44588198-A8B07C6B-4E09-439E-8508-E93AB9BBC9B7Q48154363-33E3E166-FCA6-4507-BBD3-1A18602FEADEQ53512628-50EB9E69-2470-4B91-86DF-36006F9DF145Q54257606-E1536585-0CA3-481B-9C93-98928AF7D6DEQ54379654-B7C98B15-FC81-4E46-815C-2F4537B20496Q54477697-A0F75781-E0E1-46C9-AFDD-750280312B99Q54567449-B735C416-1B5C-4199-B4D1-43BC2E002A66
P2860
Proficiency testing of immunohistochemical biomarker assays in breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proficiency testing of immunohistochemical biomarker assays in breast cancer.
@en
Proficiency testing of immunohistochemical biomarker assays in breast cancer.
@nl
type
label
Proficiency testing of immunohistochemical biomarker assays in breast cancer.
@en
Proficiency testing of immunohistochemical biomarker assays in breast cancer.
@nl
prefLabel
Proficiency testing of immunohistochemical biomarker assays in breast cancer.
@en
Proficiency testing of immunohistochemical biomarker assays in breast cancer.
@nl
P2093
P1433
P1476
Proficiency testing of immunohistochemical biomarker assays in breast cancer.
@en
P2093
Annette Fisseler-Eckhoff
Hans Kreipe
Josef Rüschoff
Reinhard von Wasielewski
Svenja Hasselmann
P2888
P304
P356
10.1007/S00428-008-0688-4
P577
2008-10-29T00:00:00Z